Should you buy Alcon (ALC)?
Updated
Alcon's confirmed price downtrend and a put-to-call ratio of 3.70 reflect significant near-term bearish sentiment — though rising analyst estimates, 19% upside to the consensus target, and strong cash conversion suggest the setup could improve materially if the earnings momentum visible in three of the past four quarters persists.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
| Pillar | Expectation | Trend |
|---|---|---|
The stock has formed a death cross, is trading below its 200-day moving average with the long-term average declining at 3.8% per 30 days, and on-balance volume is falling — a confirmed downtrend that typically requires fundamental catalysts to reverse, not just improving estimates. Momentum breakdown | Price closing above the 200-day moving average and the moving average slope turning flat or positive would signal the downtrend has reversed. | →Stable |
| CounterThe MACD is improving despite the death cross and RSI is at 45 — not at oversold extremes — suggesting the technical setup may be in early-stage recovery rather than continued steep deterioration. | ||
A put-to-call ratio of 3.70 indicates options market participants are positioned for downside at nearly four-to-one over calls — a level of bearish concentration that can act as a sustained technical drag on price recovery, particularly when combined with negative price momentum. Key risks | The put-to-call ratio declining below 1.5 over the next 90 days would indicate the bearish options positioning has substantially unwound. | →Stable |
| CounterAn elevated put-to-call ratio can also reflect institutional holders hedging existing long positions for protection rather than expressing a directional short view — if so, the positioning becomes fuel for a sharp recovery when removed. | ||
Analyst earnings estimates have risen 5.3% over the past 30 days and three of the past four quarters produced positive earnings surprises — signals that the business may be stabilizing faster than its subdued growth score implies. Catalyst breakdown | Estimates continuing to rise by at least 3% over the next 90 days would indicate analysts are gaining confidence in the earnings trajectory. | →Stable |
| CounterThe average earnings surprise is only 3.1% above consensus, a thin margin that could flip to misses if execution stumbles or macroeconomic conditions shift against the medical instruments end market. | ||
The stock has formed a death cross, is trading below its 200-day moving average with the long-term average declining at 3.8% per 30 days, and on-balance volume is falling — a confirmed downtrend that typically requires fundamental catalysts to reverse, not just improving estimates.
→Stable- Expectation
- Price closing above the 200-day moving average and the moving average slope turning flat or positive would signal the downtrend has reversed.
CounterThe MACD is improving despite the death cross and RSI is at 45 — not at oversold extremes — suggesting the technical setup may be in early-stage recovery rather than continued steep deterioration.
A put-to-call ratio of 3.70 indicates options market participants are positioned for downside at nearly four-to-one over calls — a level of bearish concentration that can act as a sustained technical drag on price recovery, particularly when combined with negative price momentum.
→Stable- Expectation
- The put-to-call ratio declining below 1.5 over the next 90 days would indicate the bearish options positioning has substantially unwound.
CounterAn elevated put-to-call ratio can also reflect institutional holders hedging existing long positions for protection rather than expressing a directional short view — if so, the positioning becomes fuel for a sharp recovery when removed.
Analyst earnings estimates have risen 5.3% over the past 30 days and three of the past four quarters produced positive earnings surprises — signals that the business may be stabilizing faster than its subdued growth score implies.
→Stable- Expectation
- Estimates continuing to rise by at least 3% over the next 90 days would indicate analysts are gaining confidence in the earnings trajectory.
CounterThe average earnings surprise is only 3.1% above consensus, a thin margin that could flip to misses if execution stumbles or macroeconomic conditions shift against the medical instruments end market.
▸ Show 1 more pillar▾ Show fewer
Free cash flow converts at 146% of net income, above what reported earnings alone suggest, and a Piotroski F-Score of 8 out of 9 reflects solid balance sheet health — a quality foundation that provides downside support even when top-line growth is subdued.
→Stable- Expectation
- Free cash flow remaining above net income for the next four quarters would confirm the cash conversion quality is structural rather than a one-period anomaly.
CounterStrong free-cash-flow conversion with weak revenue growth can indicate a business harvesting cash from existing assets rather than reinvesting for growth, which limits future earnings power if the pattern persists.
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1The stock has formed a death cross, is trading below its 200-day moving average with the long-term average declining at 3.8% per 30 days, and on-balance volume is falling — a confirmed downtrend that typically requires fundamental catalysts to reverse, not just improving estimates.
Trip ifStock closes above the 200-day moving average for more than 20 consecutive trading days.
- P2A put-to-call ratio of 3.70 indicates options market participants are positioned for downside at nearly four-to-one over calls — a level of bearish concentration that can act as a sustained technical drag on price recovery, particularly when combined with negative price momentum.
Trip ifPut-to-call ratio declines below 1.0 for 2 consecutive weeks.
- P3Analyst earnings estimates have risen 5.3% over the past 30 days and three of the past four quarters produced positive earnings surprises — signals that the business may be stabilizing faster than its subdued growth score implies.
Trip ifAnalyst EPS estimate revisions turn negative, falling more than 3% over any 30-day period in the next 12 months.
- P4Free cash flow converts at 146% of net income, above what reported earnings alone suggest, and a Piotroski F-Score of 8 out of 9 reflects solid balance sheet health — a quality foundation that provides downside support even when top-line growth is subdued.
Trip ifFree-cash-flow-to-net-income ratio falls below 80% for 2 consecutive quarters.
How the engine reached this verdict
TrendMatrix's engine output for Alcon Inc. (ALC) is HOLD_IF_HOLDING with medium conviction, score 5.1/10 at $68.56. The F-path SELL output reflects an overall score of 5.1 below the 5.4 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. Asymmetry R:R of 2.24 is supplementary context, not the trigger.
On the bull side: Strong earnings beat streak (3/4); Earnings estimates trending UP. On the bear side: Weak growth; Below 200-MA, MA slope -3.4%/30d (confirmed downtrend). Active engine warnings: L3:NEWS_MOD=+1: SELL_IF_HOLDING → HOLD_IF_HOLDING.
The engine is not issuing fresh-money entry targets at the current verdict. The technical entry zone is around — with a technical stop near $65.64 for existing positions. Asymmetric R:R is 3.69, below the threshold (≥2.0) at which the engine would actively flag fresh capital. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
Alcon Inc. (ALC) sits at overall score 5.1/10 with no actively-failing gates (strongest-cleared: MOMENTUM:5.7>=5.5). HOLD flips toward BUY_WAIT when a positive-conviction path (C-quality or D-momentum) triggers; toward SELL when any of the currently-passing gates drop below threshold or three+ dimensions fall below 4 simultaneously.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates ALC — 10-dimension breakdown →
Bull case
- ▸Strong earnings beat streak (3/4)
- ▸Earnings estimates trending UP
Bear case
- ▸Weak growth
- ▸Below 200-MA, MA slope -3.4%/30d (confirmed downtrend)